China SXT Pharmaceuticals, Inc. (SXTC)

NASDAQ: SXTC · IEX Real-Time Price · USD
0.187
-0.005 (-2.71%)
At close: Jan 21, 2022 4:00 PM
0.195
0.008 (4.234%)
After-hours:Jan 21, 2022 7:59 PM EST

Company Description

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China.

It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

The company provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of July 31, 2021, its end-customer base includes 70 pharmaceutical companies, 12 chain pharmacies, and 59 hospitals in 10 provinces and municipalities in China, including Jiangsu, Hubei, Shandong, Guangdong, Liaoning, Anhui, Henan, Jiangxi, Heilongjiang, and Hainan.

The company was founded in 2005 and is based in Taizhou, China.

China SXT Pharmaceuticals, Inc.
CountryBritish Virgin Islands
Founded2005
IPO DateJan 4, 2019
IndustryPersonal Products
SectorConsumer Staples
Employees96

Contact Details

Address:
Sertus Chambers
Po Box 905, Road Town VG1110
British Virgin Islands
Phone86 523 8629 8290
Websitesxtchina.com

Stock Details

Ticker SymbolSXTC
ExchangeNASDAQ
Fiscal YearApril - March
Reporting CurrencyUS Dollars
IPO Price$4.00
CIK Code0001723980

Key Executives

NamePosition
Feng ZhouChairman and Chief Executive Officer
Wang L. LeeChief Financial Officer
Dr. Jingzhen DengChief Scientific Officer and Chief Operating Officer
Jun ZhengExecutive Director

Latest SEC Filings

DateTypeTitle
Jan 18, 2022424B5Prospectus [Rule 424(b)(5)]
Jan 14, 20226-KReport of foreign issuer [Rules 13a-16 and 15d-16]
Aug 27, 2021S-8Securities to be offered to employees in employee benefit plans
Aug 13, 202120-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]
Aug 2, 2021NT 20-FNotification of inability to timely file Form 20-F
May 26, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
May 17, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
Apr 8, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
Mar 2, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
Feb 16, 20216-KReport of foreign issuer [Rules 13a-16 and 15d-16]
View All SEC Filings